Mirum Pharmaceuticals, Inc. posts full-year 2025 financial results and outlines key business updates and strategic priorities for 2026. Mirum Pharmaceuticals, Inc. a leading biopharmaceutical company focused on rare diseases, reported strong fourth quarter and full-year 2025 financial results, while outlining…
Swiss neurotech spin-off accelerates development of ultra-high-resolution intraoperative imaging to enhance precision and safety in brain surgery. The Wyss Center for Bio and Neuroengineering has announced the successful closing of the Seed financing round for Clee Medical SA, a promising…
SystImmune and Bristol Myers Squibb announce interim Phase III data showing Iza-bren significantly improves outcomes in previously treated triple-negative breast cancer (TNBC) patients. SystImmune, Inc. and Bristol Myers Squibb have announced positive topline results from a pivotal Phase III clinical…
The agreement grants worldwide rights to two clinical-stage NSCLC therapies, expanding Kairos Pharma’s oncology pipeline through a strategic asset acquisition from Celyn Therapeutics. Kairos Pharma, Ltd. has announced the signing of a term sheet to acquire two clinical-stage oncology assets…
The U.S. Food and Drug Administration Accepts Supplemental NDA for Accelerated Evaluation, Setting a PDUFA Target Action Date of June 30, 2026 Ionis Pharmaceuticals, Inc. has announced a significant regulatory milestone for its investigational therapy olezarsen, as the U.S. Food…
Evox Therapeutics Ltd collaborates with Rett Syndrome Research Trust to evaluate its ExoEdit® exosome-based gene editing platform as a potential therapeutic approach for Rett syndrome. Evox Therapeutics Ltd has announced the launch of a new strategic collaboration with the Rett…
New findings reinforce the clinical value of Aventa Lymphoma test for detecting diagnostically and therapeutically relevant genomic rearrangements in routine pathology samples. Arima Genomics, Inc., a precision oncology company harnessing whole-genome sequence and structural information to advance cancer therapy selection,…
New clinical study results highlight significant reductions in residual stone volume and follow-up health complications with Calyxo’s CVAC System. Calyxo, Inc., a medical device innovator transforming the treatment of kidney stones, has announced the peer-reviewed publication of pivotal clinical data…
ENDRA Life Sciences Demonstrates High Consistency in TAEUS® Liver Device for MASLD Monitoring ENDRA Life Sciences Inc , a leading innovator in thermoacoustic imaging technology, has reported highly favorable results from a recent clinical study evaluating the measurement consistency and…
Sierra Space Appoints Dan Jablonsky as Chief Executive Officer to Drive Next Phase of Growth Across National Security and Space Markets Sierra Space, a leading aerospace and defense technology company recognized for delivering critical solutions to the nation’s most strategic…